Precision Biologics, Inc. — Form D/A
Precision Biologics, Inc. of Rockville, MD, a company, filed a Form D amendment with the SEC on 2013-05-21. The offering totals $7.5M, of which $3.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-05-21
- Form: D/A
- Accession: 0001560075-13-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $7.5M
- Amount sold: $3.3M
- Remaining: $4.2M
- Investors: 85
- Date of first sale: 2013-03-31
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-196855
Issuer
- Name: Precision Biologics, Inc.
- CIK: 0001560075
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 11300 Rockville Pike, Rockville, MD, 20852
- Phone: 301-917-6890
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Patrick M Soon-Shiong | Director | Culver City, CA |
| Christian M Zapf | Director | Culver City, CA |
| Charles M Kim | Director | Culver City, CA |
| R.J. B Childress | Executive Officer | Dallas, TX |
| Mark B Kristen | Director | College Station, TX |
| Severin B Russo | Director | Leetsdale, PA |
| Sheldon B Rabin | Director | Great Neck, NY |
| Stanley B Archibald, Jr. | Director | Dallas, TX |
| Stanley B Archibald, Jr. | Promoter | Dallas, TX |
| Albine K Martin | Executive Officer | Silver Spring, MD |
| Robert A Washington | Executive Officer | Beaver Falls, PA |
| Philip M Arlen | Director | Bethesda, MD |
| Philip M Arlen | Executive Officer | Bethesda, MD |
| C. Brent Haggard | Director | Dallas, TX |
Other filings by this issuer (5)
More